Publications

Published: 10 June 2015

MARC's Remarks: March 2015 Meeting

Prescriber Update 36(2): 26
June 2015

The Medicines Adverse Reactions Committee (MARC) met on 12 March 2015 to consider:

The MARC agreed that the ibuprofen data sheets should be harmonised so that information about cardiovascular risks is clear and consistent across all data sheets. In addition, the MARC recommended that Medsafe communicates information about cardiovascular risks to consumers and healthcare professionals.

Further information on this meeting can be found on the Medsafe website (www.medsafe.govt.nz/profs/adverse/Minutes161.htm).

References
  1. Medsafe. 2015. Risk of inhibitor development with factor VIII replacement products. Prescriber Update 36(2): 21.
  2. Medsafe. 2015. Macrolides — don’t upset the rhythm. Prescriber Update 36(2): 22.